Researchers have used 3D nanotechnology to successfully grow human retinal cells, opening the door to a new way of treating age-related macular degeneration, a leading cause of blindness in the developed world.
I wonder if this technique can be expanded to other eye conditions 🤔
Here is a Tl;Dr for the ones which don’t want to click the link:
Researchers at Anglia Ruskin University in the UK have used 3D nanotechnology to successfully grow human retinal cells, offering a new way to treat age-related macular degeneration (AMD), a leading cause of blindness.
AMD is categorized into two types: ‘dry’ and ‘wet,’ both of which cause vision loss due to the destruction or deterioration of the retina’s RPE cells.
The team used electrospinning, a novel technique in this context, to create a 3D nanofibrous scaffold, composed of two polymers, which served as a base for growing the RPE cells. An anti-inflammatory coating was applied to the scaffold, enhancing the growth and functionality of the cells, which remained healthy and viable for up to 150 days.
This innovative approach could lead to effective treatments for sight conditions like AMD, and the researchers are now focusing on transplanting these freshly grown cells into the human eye.
I wonder if this technique can be expanded to other eye conditions 🤔
Here is a Tl;Dr for the ones which don’t want to click the link:
Researchers at Anglia Ruskin University in the UK have used 3D nanotechnology to successfully grow human retinal cells, offering a new way to treat age-related macular degeneration (AMD), a leading cause of blindness.
AMD is categorized into two types: ‘dry’ and ‘wet,’ both of which cause vision loss due to the destruction or deterioration of the retina’s RPE cells.
The team used electrospinning, a novel technique in this context, to create a 3D nanofibrous scaffold, composed of two polymers, which served as a base for growing the RPE cells. An anti-inflammatory coating was applied to the scaffold, enhancing the growth and functionality of the cells, which remained healthy and viable for up to 150 days.
This innovative approach could lead to effective treatments for sight conditions like AMD, and the researchers are now focusing on transplanting these freshly grown cells into the human eye.